{{Rsnum
|rsid=716595
|Gene=MXI1
|Chromosome=10
|position=112006486
|Orientation=plus
|GMAF=0.1483
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 13.3 | 86.7
| HCB | 8.1 | 36.8 | 55.1
| JPT | 12.4 | 43.4 | 44.2
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 8.8 | 91.2
| CHB | 8.1 | 36.8 | 55.1
| CHD | 15.7 | 41.7 | 42.6
| GIH | 0.0 | 28.7 | 71.3
| LWK | 0.0 | 0.9 | 99.1
| MEX | 14.0 | 47.4 | 38.6
| MKK | 0.0 | 5.1 | 94.9
| TSI | 0.0 | 19.6 | 80.4
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19010793
|Trait=Normalized brain volume
|Title=Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
|RiskAllele=
|Pval=0.000008
|OR=NR
|ORtxt=NR
}}

{{PharmGKB
|RSID=rs716595
|Name_s=
|Gene_s=MXI1
|Feature=
|Evidence=PubMed ID:19010793; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. (Initial Sample Size: 753 cases, 883 controls; Replication Sample Size: NR); (Region: 10q25.2; Reported Gene(s): MXI1; Risk Allele: rs716595-?); (p-value= 0.000008).This variant is associated with Normalized brain volume.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740739
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs716595
|overall_frequency_n=17
|overall_frequency_d=128
|overall_frequency=0.132812
|n_genomes=15
|n_genomes_annotated=0
|n_haplomes=17
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}